New Jersey cannabis regulators create new permit to allow “clinically focused” dispensaries to partner with research institutions to conduct cannabis research with products they grow or sell to patients Public comments are being accepted on the proposal.
The New Jersey Cannabis Control Commission (CRC) will create a “Clinical Registrar Permit” that will allow for more targeted research into the “therapeutic or palliative effects of medical cannabis,” among other research topics. He said he is seeking to amend the state's cannabis laws. Relying on outsourced products.
Clinical registrants, like other traditional dispensary licensees, will be authorized to engage in activities such as growing, manufacturing, and selling marijuana. However, they will also be able to enter into a “written contractual relationship with an academic medical center in the area where their principal place of business is located” to “engage in clinical research related to the use of medical marijuana.”
In other words, researchers will be able to conduct clinical trials on patients across the state using the very products patients are purchasing from pharmacies.
The comments you provide will help shape what is ultimately adopted. The comment period for clinical registrants will end on October 6, 2023. Details: https://t.co/IrGgxnUNTV pic.twitter.com/hVEM31K999
— New Jersey Cannabis Control Commission (@NewJerseyCRC) September 6, 2023
The proposed rule states, “Clinical registrants may dispense usable medical cannabis and medical cannabis products directly to academic medical centers as part of research studies in any format approved by an Institutional Review Board (IRB).” It is stated that “it is possible to do so.” “Academic medical centers that handle medical cannabis products must do so in a manner consistent with standards for academic medical centers used to handle, store, and dispose of other patient medications.”
Clinical registrants could not “simultaneously hold a non-clinical medical cannabis grower, medical cannabis manufacturer, medical cannabis dispensary license, or personal use cannabis business license.” And, academic research institutions affiliated with registrants may receive “no value for money” from clinical specialty pharmacies “except for reasonable remuneration, specifically in research agreements for services and costs performed by academic medical centers.” I couldn't receive what I had. ”
Public comments on the proposal are being accepted until October 6th.
“The Commission finds that the proposed new rules for clinical registrar licensing fully accomplish the statutory purpose of providing safe access to medical cannabis for patients in need by authorizing additional license types. We hope that this will have a positive social impact in achieving the
A new permit type would force scientists to not only go through a cumbersome registration process with the Drug Enforcement Administration (DEA) to access cannabis for research, but also to use government-grown cannabis products. It is often lower quality and less potent than cannabis available on state legal markets, which could help fill the research gaps imposed under federal prohibition.
This is an issue that representatives from multiple federal agencies discussed at a meeting last week.
Nora Volkow, director of the National Institute on Drug Abuse (NIDA), has herself expressed support for allowing researchers to study cannabis from state-licensed retailers.
The bill signed by President Joe Biden last year aims to streamline the marijuana research process, but lawmakers have removed a provision included in the House version that would have allowed scientists to obtain cannabis from licensed dispensaries. The bill was passed without exception.
Much of the federal research agenda on cannabis could be improved under the U.S. Department of Health and Human Services (HHS) recommendation to move cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA) . But it is not yet clear whether the Drug Enforcement Administration (DEA) will follow that recommendation.
New federal data shows record number of banks partnering with cannabis businesses as Senate plans to vote on reform bill
Photo courtesy: WeedPornDaily
Marijuana Moment is made possible by support from our readers. If you rely on his cannabis advocacy journalism to stay informed, please consider his monthly Patreon pledge.
